Upperton Pharma Solutions
Jack Lakin is a Senior Scientist 1 at Upperton Pharma Solutions since October 2021, previously serving as a Quality Control Scientist 2. Prior to this role, Jack worked at Catalent Pharma Solutions from February 2020 to October 2021 as a Quality Control Scientist. Jack earned a Master's degree in Chemistry from Newcastle University, where studies were completed between September 2015 and July 2019.
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.